Laparoscopy/Robotics

Introduction {#s0005}
============

Schistosomes (bilharzia) are parasites that have been documented to cause urinary disease in humans since ancient times, as recorded in Egyptian papyri, notably those of Eber and Edwin Smith [@b0005]. Schistosomiasis is the second most important parasitic infection after malaria and affects \>200 million people in 74 countries [@b0010]. It is endemic, with high prevalence and morbidity rates, in many countries, especially those in Africa, such as Egypt and Kenya, and in South America, mainly Brazil, with a prevalence of 15--45% in Egypt and Brazil [@b0015; @b0020; @b0025].

Commonly, ureteric lesions are limited to the lower half, at the level of the third lumbar vertebra, which is due to anastomotic channels between the inferior mesenteric and the peri-ureteric and peri-vesical veins. These communications are thought to be the main route through which *Schistosoma haematobium* worms migrate to the urinary system. The lower ureteric lesions in schistosomiasis include early tubercles and ulcers, and subsequently the sandy patches and cysts, known as 'ureteritis cystica'. Fibrosis of the lower ureteric musculosa can lead to partial obstruction; the upper ureter compensates by dilatational hypertrophy that generates enough bolus pressure to overcome the distal obstruction, thereby protecting the kidneys from back pressure [@b0030].

Laparoscopic ureterolithotomy (LU) is a safe well-established treatment option for managing ureteric stones, replacing conventional surgery [@b0035; @b0040]. LU causes less pain, and has a minimal analgesic requirement, a short hospital stay, a shorter recovery phase and better cosmesis [@b0045; @b0050]. LU is done using one of two basic approaches, transperitoneal or retroperitoneal, and each has its advantages and disadvantages [@b0055; @b0060; @b0065].

Bilharzial ureters are complicated mainly by the distal stricture caused by the precipitation of bilharzial ova at the vesico-ureteric junction and distal ureter. This is associated with poorly functioning and grossly hydronephrotic kidneys that hinder the endoscopic manipulation of the coexistent distal, high-burden, long-standing impacted stones making it technically unfeasible [@b0070].

In the present study we aimed to determine the efficacy and safety of the laparoscopic management of an impacted distal ureteric stone in bilharzial patients.

Patients and methods {#s0010}
====================

This prospective study follows the tenets of the declaration of Helsinki. We used transperitoneal LU in 51 bilharzial patients (33 men and 18 women) who had large radio-opaque distal ureteric stones, during the period from June 2010 to June 2013. All patients were assessed by IVU and this showed gross hydronephrosis in 45 renal units. The inclusion criteria were: large lower ureteric stones (⩾1 cm) visible on a plain film and not amenable to ureteroscopic extraction, hydronephrosis associated with a history of antibilharzial treatment for confirmed bilharzial ova on urine analysis, a radiological appearance of the spindle-shaped lower ureteric stricture characteristic of bilharzial infection, or the presence of ureteritis cystica on ureteroscopy.

Surgical technique {#s0015}
------------------

The procedure usually starts with cystoscopy and insertion of an open-tip 6 F ureteric catheter, and then the stone side is laterally tilted to 45°. The LU was performed through four ports, comprising two 10-mm and two 5-mm trocars. After reflecting the colon, the ureter was identified and the stone located and extracted through vertical ureterotomy. The stone was identified by an obvious bulge, or pinching by Maryland forceps. Upward migration of the stone was prevented by applying a laparoscopic Babcock forceps on the ureter above the stone bulge, which was replaced by a vessel tape in some cases, according to the surgeon's preference. This was followed by ureterotomy and stone extraction ([Fig. 1](#f0005){ref-type="fig"}). A 6 F JJ stent was then inserted and the ureterotomy closed with 4/0 polyglactin sutures. Using a 5-mm endoscope, the stone was extracted in a sac through the 10-mm port and then a small drain was inserted via the other 5-mm port.

The data collected included patient age, sex, stone details (size, number and laterality) and any history of stone surgery or ESWL. Operative data included the type of anaesthesia applied, operative duration, mean intraoperative blood loss, and the frequency of conversion to open surgery. Postoperative data included pain severity, judged using 100-point visual analogue scale with 0 = no pain and 100 = the worst intolerable pain, the duration until the first request and the number of requests for analgesia, the time to resuming oral intake, time to first mobilisation, and the duration of hospital stay. The follow-up data included the duration of follow-up, any stone recurrence, ureteric stricture formation, and any other complications.

Results {#s0020}
=======

The results are shown in [Table 1](#t0005){ref-type="table"}; conversion to open surgery was reported in only one patient. The stone recurred in four patients (8%) during the follow-up, and all were small and passed spontaneously with medical treatment. A ureteric stricture was reported in two patients (4%) and these were managed endoscopically. All patients were rendered stone-free rate.

Discussion {#s0025}
==========

LU or open ureterolithotomy can be used as the primary treatment of large, impacted ureteric stones of \>1 cm, or as a salvage procedure if ESWL fails or after attempted ureteroscopy and percutaneous nephrolithotomy [@b0070; @b0075; @b0080].

As LU can access all locations in the ureter, LU by the transperitoneal route is the preferred technique for ureteric stones [@b0085; @b0090]. The advantages of the transperitoneal route included a large peritoneal space for instrument handling and intracorporal suturing, making the procedure comparatively easy [@b0095]. In addition, the transperitoneal approach gives a better understanding of the anatomical landmarks, particularly for a lower ureteric stone [@b0055]. Thus we used this technique in the present study.

In the present study all patients were ultimately stone-free (complete clearance of the stones). These results are comparable to those of previous studies, where it was reported that a high success rate depends upon correct patient selection and the surgical experience of the laparoscopic technique. The success rates of transperitoneal LU are 86--100% [@b0085; @b0100; @b0105; @b0110]. Further studies showed that with increase in experience, the overall success rate is \>90% [@b0040; @b0115].

In the present study the mean (SD, range) operative duration was 92.1 (10.60, 75--120) min; El-Feel et al. [@b0120] reported a mean duration of 145 (55--180) min. The present operative duration seemed to be longer than in other previous reports, and this can be attributed to the fact that we operated only on lower ureteric stones, while previous reports included stones in all segments in the ureter. For lower ureteric stones the ureter was dissected with extra caution, where the space was less, and as the ureter was crossing the iliac vessels there were more chances of vascular injury. Compared to other locations the overall procedure time was more for stones which were in the lower ureter [@b0125]. Abolyosr et al. [@b0130] reported that upper and mid ureteric stones can be safely approached retroperitoneally, but for lower ureteric stones transperitoneal approach is a much better option, as it gives a better understanding of the anatomical landmarks, particularly in the lower part of the ureter.

The overall complication rate in the present study was 11.7% (conversion, re-stricture and stone recurrence). This is in line with previous reports, where the overall reported mean complication rate of laparoscopic transperitoneal urological surgery is 14.1--19% [@b0135; @b0140] and for transperitoneal ureterolithotomy, the rate was 4--18% in different series [@b0100; @b0120; @b0145]. Feyaerts et al. [@b0105] reported an overall 8.3% complication rate of transperitoneal LU, and El-Feel et al. [@b0120] reported 4% and Simforoosh et al. [@b0100] reported 12.2%, respectively. In an interesting study, Basiri et al. [@b0085] reported an 18% complication rate, in the form of leakage of urine for \>3 days.

The present mean (SD, range) duration of hospital stay was 2.7 (0.91, 2--5) days. Feyaerts et al. [@b0105] reported a mean hospital stay of 3.8 days, El-Feel et al. [@b0120] of 4.1 days and Basiri et al. [@b0085] of 5.8 (2.3) days. Fang et al. [@b0150] reported LU to give a higher stone clearance rate and shorter operating time than ureteroscopic lithotripsy.

The present study had several limitations: it did not include patients with previous ureteric surgery or those with multiple stones. The patients were operated by several surgeons with different levels of experience.

In conclusion, we showed that LU is a safe and effective minimally invasive procedure for distal ureteric stones in the bilharzial ureter that were not otherwise amenable to endoscopic extraction.
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###### 

The pre- and postoperative characteristics of the 51 patients.

  Variable                         Mean (SD, range) or *n* (%)
  -------------------------------- ----------------------------------------------
  Gender (male/female)             33/18 (64.7/35.3)
  Hydronephrosis                   45 (88.2)
  Laterality (right/left)          29/22 (56.9/43.1)
  Previous endoscopic dilatation   22 (43.1)
  Conversion to open surgery       1 (2.0)
  Number of analgesic requests     
   1                               21 (41.2)
   2                               23 (45.1)
   3                               7 (13.7)
  Stone recurrence                 4 (7.8)
  Ureteric stricture               2 (3.9)
  Age (years)                      40.1 (6.90, 22--54)
  Stone size (mm)                  2.73 (0.18, 23--54)
  Operative duration (min)         92.1 (10.60, 75--120)
  Blood loss (mL)                  70.9 (17.16, 30--100)
  Pain score                       45[⁎](#tblfn1){ref-type="table-fn"} (20--60)
  Analgesia                        
   Time to first request (min)     100.3 (43.15, 30--195)
   No. of requests                 1.72 (0.69, 1--3)
  First mobilisation (h)           2.09 (0.34, 1.50--3)
  Resumed oral intake (h)          6.03 (1.44, 4--9)
  Hospital stay (days)             2.74 (0.91, 2--5)
  Total follow-up (months)         9.68 (1.63, 7--12)

Median.
